Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System

Changes in Proximal Tubular Reabsorption Modulate Microvascular Regulation via the TGF System

This review paper considers the consequences of modulating tubular reabsorption proximal to the macula densa by sodium–glucose co-transporter 2 (SGLT2) inhibitors, acetazolamide, and furosemide in states of glomerular hyperfiltration. SGLT2 inhibitors improve renal function in early and advanced dia...

Full description

Bibliographic Details
Main Authors:	Shayan Poursharif, Shereen Hamza, Branko Braam
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	International Journal of Molecular Sciences
Subjects:	tubuloglomerular feedback SGLT2 inhibitors furosemide diabetic nephropathy acetazolamide nephrovascular unit
Online Access:	https://www.mdpi.com/1422-0067/23/19/11203

Similar Items

Diuretic resistance and the role of albumin in congestive heart failure
by: Carol Fernandez Hazim, et al.
Published: (2023-12-01)

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors: Renoprotective Mechanisms beyond Glycemic Control
by: Tomoaki Takata, et al.
Published: (2021-04-01)

Modeling renal autoregulation in a hemodynamic, first‐trimester gestational model
by: Maaike vanOchten, et al.
Published: (2022-10-01)

Animated Model of Glomerular Filtration Regulation (Out of Print)
by: Jody Gookin, et al.
Published: (2010-01-01)

Interacting information streams on the nephron arterial network
by: Donald J. Marsh, et al.
Published: (2023-10-01)

Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice
by: Hideyuki Okuma, et al.
Published: (2021-07-01)

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats
by: Manal M.G. Mourad*, et al.
Published: (2023-07-01)

Diabetic nephropathy: newer therapeutic perspectives
by: Krishna C. Keri, et al.
Published: (2018-07-01)

Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in Mice
by: Jin Joo Cha, et al.
Published: (2024-01-01)

Acetazolamide for Bipolar Disorders: A Scoping Review
by: Rebecca Strawbridge, et al.
Published: (2023-01-01)

Empagliflozin: a new strategy for nephroprotection in diabetes
by: Anton Ivanovich Korbut, et al.
Published: (2017-05-01)

Role of Sodium-Glucose Co-Transporter 2 Inhibitors in Chronic Kidney Disease, Congestive Heart Failure and Stroke—A Review and Clinical Guide for Healthcare Professionals
by: Prabhat Singh, et al.
Published: (2023-09-01)

Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases
by: Kai-Fan Tsai, et al.
Published: (2021-07-01)

IgA nephropathy: a review of existing and emerging therapies
by: Sahibzadi Mahrukh Noor, et al.
Published: (2023-05-01)

Efficacy of Acetazolamide in Refractory Epilepsy Management: A Quasi-Experimental Study
by: Muhammad Ahmed Zamir, et al.
Published: (2023-06-01)

ANÁLISE DE CONTROLE DE DOPING POR ACETAZOLAMIDA UTILIZANDO O SENSOR ELETROQUÍMICO BASEADO NO EPCM-[MnIII/IV(µ-O)(phen)2]2(ClO4)3
by: Wesley Bruno da Silva Machini, et al.
Published: (2014-09-01)

Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
by: Davide Viggiano
Published: (2023-10-01)

Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARγ/CD36 Pathway in Obese Mice
by: Chiang-Chi Huang, et al.
Published: (2021-11-01)

Novel Anthraquinone-Based Benzenesulfonamide Derivatives and Their Analogues as Potent Human Carbonic Anhydrase Inhibitors with Antitumor Activity: Synthesis, Biological Evaluation, and In Silico Analysis
by: Shanshan Wu, et al.
Published: (2024-03-01)

Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives
by: Alfredo Fabrizio Lo Faro, et al.
Published: (2022-09-01)

Dapaglifozin on Albuminuria in Chronic Kidney Disease Patients with FabrY Disease: The DEFY Study Design and Protocol
by: Yuri Battaglia, et al.
Published: (2023-05-01)

Effects of sodium-glucose co-transporter 2 (SGLT2) inhibition on renal function and albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis
by: Lubin Xu, et al.
Published: (2017-06-01)

Sodium Glucose Cotransporter-2 Inhibitor Empagliflozin Increases Antioxidative Capacity and Improves Renal Function in Diabetic Rats
by: Habib Yaribeygi, et al.
Published: (2023-06-01)

Nephrocalcinosis fortuitously discovered: the role of surreptitious self administration of diuretics
by: Nery Sablon Gonzalez, et al.
Published: (2024-01-01)

Effects of Acetazolamide on Collagen Metabolism in Keratoconus Fibroblasts
by: Yunpeng XIE, et al.
Published: (2023-01-01)

Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption
by: Keiko Unno, et al.
Published: (2023-03-01)

Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models
by: Giovanna Castoldi, et al.
Published: (2024-03-01)

A Transcriptome Array-Based Approach to Link SGLT-2 and Intrarenal Complement C5 Synthesis in Diabetic Nephropathy
by: Peter Korsten, et al.
Published: (2023-12-01)

IgA Nephropathy: Current Treatment and New Insights
by: Dimitra Petrou, et al.
Published: (2023-06-01)

Renal Oxygen Demand and Nephron Function: Is Glucose a Friend or Foe?
by: Edoardo Gronda, et al.
Published: (2023-06-01)

Prevalence and severity of exercise‐induced pulmonary hemorrhage in 2‐year‐old Thoroughbred racehorses and its relationship to performance
by: Sierra Shoemaker, et al.
Published: (2024-03-01)

The Use of Diuretic in Mechanically Ventilated Children with Viral Bronchiolitis: A Cohort Study
by: Agasthya Nisha, et al.
Published: (2021-05-01)

Administration of Intravenous Furosemide in Patients with Acute Infection: Patient Characteristics and Impact on In-Hospital Outcome
by: Nir Levi, et al.
Published: (2023-05-01)

Three Levels of Disease Modification with SGLT-2 Inhibitors: Holy Grail in Vasculopathy
by: Archit Dhaiya; Rajeev Sharma; Nagendra Bhoopathy; Rajeev Agarwal
Published: (2023-07-01)

Design, synthesis, and molecular docking studies of N-substituted sulfonamides as potential anticancer therapeutics
by: Ibrahim T. Babalola, Ph.D, et al.
Published: (2024-02-01)

Comprehensive Exonic Sequencing of Known Ataxia Genes in Episodic Ataxia
by: Neven Maksemous, et al.
Published: (2020-05-01)

A pilot open-label study of oral acetazolamide for sodium valproate-associated weight gain in bipolar affective disorder
by: Mathews Joseph Panicker, et al.
Published: (2022-01-01)

Efficacy of SGLT2 inhibitors in IgA nephropathy associated with alcoholic liver cirrhosis accompanied by nephrotic syndrome: a case report
by: Yusuke Yoshimura, et al.
Published: (2024-01-01)

Treatment and practical considerations of diabetic kidney disease
by: Yara Bilen, et al.
Published: (2023-12-01)

Targeting the pH Paradigm at the Bedside: A Practical Approach
by: Tomas Koltai
Published: (2020-12-01)